Literature DB >> 22062891

Activation of the innate immune response and interferon signalling in myotonic dystrophy type 1 and type 2 cataracts.

Jeremy D Rhodes1, Martin C Lott, Sarah L Russell, Vincent Moulton, Julie Sanderson, I Michael Wormstone, David C Broadway.   

Abstract

Myotonic dystrophy (DM) is caused by a triplet repeat expansion in the non-coding region of either the DMPK (DM1) or CNBP (DM2) gene. Transcription of the expanded region causes accumulation of double-stranded RNA (dsRNA) in DM cells. We sought to determine how expression of triplet repeat RNA causes the varied phenotype typical of DM. Global transcription was measured in DM and non-DM cataract samples using Illumina Bead Arrays. DM samples were compared with non-DM samples and lists of differentially expressed genes (P≤ 0.05) were prepared. Gene set enrichment analysis and the Interferome database were used to search for significant patterns of gene expression in DM cells. Expression of individual genes was measured using quantitative real-time polymerase chain reaction. DMPK and CNBP expression was confirmed in native lens cells showing that a toxic RNA gain of function mechanism could exist in lens. A high proportion, 83% in DM1 and 75% in DM2, of the significantly disregulated genes were shared by both forms of the disease, suggesting a common mechanism. The upregulated genes in DM1 and DM2 were highly enriched in both interferon-regulated genes (IRGs) and genes associated with the response to dsRNA and the innate immune response. The characteristic fingerprint of IRGs and the signalling pathways identified in lens cells support a role for dsRNA activation of the innate immune response in the pathology of DM. This new evidence forms the basis for a novel hypothesis to explain the complex mechanism of DM.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22062891     DOI: 10.1093/hmg/ddr515

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  20 in total

Review 1.  Neurodegenerative diseases have genetic hallmarks of autoinflammatory disease.

Authors:  Robert I Richards; Sarah A Robertson; Daniel L Kastner
Journal:  Hum Mol Genet       Date:  2018-08-01       Impact factor: 6.150

2.  PI(3,4)P2-mediated cytokinetic abscission prevents early senescence and cataract formation.

Authors:  Federico Gulluni; Lorenzo Prever; Huayi Li; Petra Krafcikova; Ilaria Corrado; Wen-Ting Lo; Jean Piero Margaria; Anlu Chen; Maria Chiara De Santis; Sophie J Cnudde; Joseph Fogerty; Alex Yuan; Alberto Massarotti; Nasrin Torabi Sarijalo; Oscar Vadas; Roger L Williams; Marcus Thelen; David R Powell; Markus Schueler; Michael S Wiesener; Tamas Balla; Hagit N Baris; Dov Tiosano; Brian M McDermott; Brian D Perkins; Alessandra Ghigo; Miriam Martini; Volker Haucke; Evzen Boura; Giorgio Roberto Merlo; David A Buchner; Emilio Hirsch
Journal:  Science       Date:  2021-12-10       Impact factor: 63.714

Review 3.  Recent advances in myotonic dystrophy type 2.

Authors:  Christina M Ulane; Sarah Teed; Jacinda Sampson
Journal:  Curr Neurol Neurosci Rep       Date:  2014-02       Impact factor: 5.081

Review 4.  The role of the immune system in triplet repeat expansion diseases.

Authors:  Marta Olejniczak; Martyna O Urbanek; Wlodzimierz J Krzyzosiak
Journal:  Mediators Inflamm       Date:  2015-03-22       Impact factor: 4.711

5.  The Enemy within: Innate Surveillance-Mediated Cell Death, the Common Mechanism of Neurodegenerative Disease.

Authors:  Robert I Richards; Sarah A Robertson; Louise V O'Keefe; Dani Fornarino; Andrew Scott; Michael Lardelli; Bernhard T Baune
Journal:  Front Neurosci       Date:  2016-05-10       Impact factor: 4.677

6.  A Molecular Signature of Myalgia in Myotonic Dystrophy 2.

Authors:  Rabih Moshourab; Vinko Palada; Stefanie Grunwald; Ulrike Grieben; Gary R Lewin; Simone Spuler
Journal:  EBioMedicine       Date:  2016-03-14       Impact factor: 8.143

7.  Two cases of myotonic dystrophy manifesting various ophthalmic findings with genetic evaluation.

Authors:  Min Ji Kang; Hye Bin Yim; Hyung Bin Hwang
Journal:  Indian J Ophthalmol       Date:  2016-07       Impact factor: 1.848

8.  CNBP acts as a key transcriptional regulator of sustained expression of interleukin-6.

Authors:  Eunhye Lee; Taeyun A Lee; Ji Hyun Kim; Areum Park; Eun A Ra; Sujin Kang; Hyun Jin Choi; Junhee L Choi; Hyunbin D Huh; Ji Eun Lee; Sungwook Lee; Boyoun Park
Journal:  Nucleic Acids Res       Date:  2017-04-07       Impact factor: 16.971

Review 9.  RNA toxicity in polyglutamine disorders: concepts, models, and progress of research.

Authors:  Agnieszka Fiszer; Wlodzimierz J Krzyzosiak
Journal:  J Mol Med (Berl)       Date:  2013-03-20       Impact factor: 4.599

Review 10.  Core Clinical Phenotypes in Myotonic Dystrophies.

Authors:  Stephan Wenninger; Federica Montagnese; Benedikt Schoser
Journal:  Front Neurol       Date:  2018-05-02       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.